Unboxing AI | Friday Webinars @ 11 AM ET | Dr Leonardo K Bittencourt, University Hospitals (July 12) | Kevin Harris, CureMetrix (July 19) | Dr Ryan Lee, Jefferson Health (July 26) | Register Now
  • 2019-01-08

Initial experiences with amide proton transfer imaging: correlation between quantitative MTRasym ratio, rCBV and rCBF values in brain tumours

Amide proton transfer (APT) imaging is a new molecular MRI technique based on chemical exchange saturation transfer mechanism with proposed use as an imaging biomarker in brain tumours. We evaluated the correlation between Asymmetric magnetization transfer ratio (MTRasym) measured on APT scans with relative cerebral blood volume (rCBV) and relative CBF (rCBF) values measured on Dynamic susceptibility contrast (DSC) MR perfusion in patients with brain tumours.

Link to complete publication here: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=dqpMNRUAAAAJ&cstart=20&pagesize=80&citation_for_view=dqpMNRUAAAAJ:_FxGoFyzp5QC

Unlock the potential of CARPL platform for optimizing radiology workflows

Talk to a Clinical Solutions Architect